![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 14, 11310-11316, April 6, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
From the Department of Pathology, State University of New York at
Stony Brook, Stony Brook, New York 11794-8691 and
The identification of upstream pathways that
signal to TP73 is crucial for understanding the
biological role of this gene. Since some evidence suggests that
TP73 might play a role in tumorigenesis, we asked whether
oncogenes can induce and activate endogenous TP73. Here, we
show that endogenous p73
Dana-Farber Cancer Institute, Harvard Medical School,
Boston, Massachusetts 02115
and
proteins are up-regulated in
p53-deficient tumor cells in response to overexpressed E2F1, c-Myc, and E1A. E2F1, c-Myc, and E1A-mediated p73 up-regulation leads to activation of the p73 transcription function, as shown by
p73-responsive reporter activity and by induction of known endogenous
p73 target gene products such as p21 and HDM2. Importantly, E2F1-,
c-Myc-, and E1A-mediated activation of endogenous p73 induces apoptosis
in SaOs-2 cells. Conversely, inactivation of p73 by a dominant
negative p73 inhibitor (p73DD), but not by a mutant p73DD, inhibits
oncogene-induced apoptosis. These data show that oncogenes can signal
to TP73 in vivo. Moreover, in the absence of
p53, oncogenes may enlist p73 to induce apoptosis in tumor cells.
This article has been cited by other articles:
![]() |
A. P. Kater, M. H. J. van Oers, and T. J. Kipps Cellular immune therapy for chronic lymphocytic leukemia Blood, October 15, 2007; 110(8): 2811 - 2818. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Klochendler-Yeivin, E. Picarsky, and M. Yaniv Increased DNA Damage Sensitivity and Apoptosis in Cells Lacking the Snf5/Ini1 Subunit of the SWI/SNF Chromatin Remodeling Complex. Mol. Cell. Biol., April 1, 2006; 26(7): 2661 - 2674. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jain, S. Gupta, Ch. Sudhakar, V. Radha, and G. Swarup Role of p73 in Regulating Human Caspase-1 Gene Transcription Induced by Interferon-{gamma} and Cisplatin J. Biol. Chem., November 4, 2005; 280(44): 36664 - 36673. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Belkhiri, A. Zaika, N. Pidkovka, S. Knuutila, C. Moskaluk, and W. El-Rifai Darpp-32: a Novel Antiapoptotic Gene in Upper Gastrointestinal Carcinomas Cancer Res., August 1, 2005; 65(15): 6583 - 6592. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Saifudeen, V. Diavolitsis, J. Stefkova, S. Dipp, H. Fan, and S. S. El-Dahr Spatiotemporal Switch from {Delta}Np73 to TAp73 Isoforms during Nephrogenesis: IMPACT ON DIFFERENTIATION GENE EXPRESSION J. Biol. Chem., June 17, 2005; 280(24): 23094 - 23102. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gonzalez, M. M. Perez-Perez, E. Hernando, M. Serrano, and C. Cordon-Cardo p73{beta}-Mediated Apoptosis Requires p57kip2 Induction and IEX-1 Inhibition Cancer Res., March 15, 2005; 65(6): 2186 - 2192. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Flinterman, L. Guelen, S. Ezzati-Nik, R. Killick, G. Melino, K. Tominaga, J. S. Mymryk, J. Gaken, and M. Tavassoli E1A Activates Transcription of p73 and Noxa to Induce Apoptosis J. Biol. Chem., February 18, 2005; 280(7): 5945 - 5959. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Meyer, A. C. Socorro, C. G. P. Garcia, L. M. Millan, N. Walker, and D. Caput Developmental Roles of p73 in Cajal-Retzius Cells and Cortical Patterning J. Neurosci., November 3, 2004; 24(44): 9878 - 9887. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. M. Moll and N. Slade p63 and p73: Roles in Development and Tumor Formation Mol. Cancer Res., July 1, 2004; 2(7): 371 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bernassola, P. Salomoni, A. Oberst, C. J. Di Como, M. Pagano, G. Melino, and P. P. Pandolfi Ubiquitin-dependent Degradation of p73 Is Inhibited by PML J. Exp. Med., June 7, 2004; 199(11): 1545 - 1557. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Oniscu, N Sphyris, R G Morris, S Bader, and D J Harrison p73{alpha} is a candidate effector in the p53 independent apoptosis pathway of cisplatin damaged primary murine colonocytes J. Clin. Pathol., May 1, 2004; 57(5): 492 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Concin, K. Becker, N. Slade, S. Erster, E. Mueller-Holzner, H. Ulmer, G. Daxenbichler, A. Zeimet, R. Zeillinger, C. Marth, et al. Transdominant {Delta}TAp73 Isoforms Are Frequently Up-regulated in Ovarian Cancer. Evidence for Their Role as Epigenetic p53 Inhibitors in Vivo Cancer Res., April 1, 2004; 64(7): 2449 - 2460. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Stiewe, S. Tuve, M. Peter, A. Tannapfel, A. H. Elmaagacli, and B. M. Putzer Quantitative TP73 Transcript Analysis in Hepatocellular Carcinomas Clin. Cancer Res., January 15, 2004; 10(2): 626 - 633. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. N. Barrera, J. A. Poveda, J. M. Gonzalez-Ros, and J. L. Neira Binding of the C-terminal Sterile {alpha} Motif (SAM) Domain of Human p73 to Lipid Membranes J. Biol. Chem., November 21, 2003; 278(47): 46878 - 46885. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gonzalez, C. Prives, and C. Cordon-Cardo p73{alpha} Regulation by Chk1 in Response to DNA Damage Mol. Cell. Biol., November 15, 2003; 23(22): 8161 - 8171. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. M. Moll The Role of p63 and p73 in Tumor Formation and Progression: Coming of Age Toward Clinical Usefulness: Commentary re: F. Koga et al., Impaired p63 Expression Associates with Poor Prognosis and Uroplakin III Expression in Invasive Urothelial Carcinoma of the Bladder. Clin. Cancer Res., 9: 5501-5507, 2003, and P. Puig et al., p73 Expression in Human Normal and Tumor Tissues: Loss of p73{alpha} Expression Is Associated with Tumor Progression in Bladder Cancer. Clin. Cancer Res., 9: 5642-5651, 2003. Clin. Cancer Res., November 15, 2003; 9(15): 5437 - 5441. [Full Text] [PDF] |
||||
![]() |
K. Lohr, C. Moritz, A. Contente, and M. Dobbelstein p21/CDKN1A Mediates Negative Regulation of Transcription by p53 J. Biol. Chem., August 29, 2003; 278(35): 32507 - 32516. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Petrenko, A. Zaika, and U. M. Moll {Delta}Np73 Facilitates Cell Immortalization and Cooperates with Oncogenic Ras in Cellular Transformation In Vivo Mol. Cell. Biol., August 15, 2003; 23(16): 5540 - 5555. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gaiddon, M. Lokshin, I. Gross, D. Levasseur, Y. Taya, J.-P. Loeffler, and C. Prives Cyclin-dependent Kinases Phosphorylate p73 at Threonine 86 in a Cell Cycle-dependent Manner and Negatively Regulate p73 J. Biol. Chem., July 18, 2003; 278(30): 27421 - 27431. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lohr, O. Hartmann, H. Schafer, and M. Dobbelstein Mutual Interference of Adenovirus Infection and myc Expression J. Virol., July 15, 2003; 77(14): 7936 - 7944. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. C. Tsai and Z.-M. Yuan c-Abl Stabilizes p73 by a Phosphorylation-augmented Interaction Cancer Res., June 15, 2003; 63(12): 3418 - 3424. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Das, W. S. El-Deiry, and K. Somasundaram Regulation of the p53 Homolog p73 by Adenoviral Oncogene E1A J. Biol. Chem., May 9, 2003; 278(20): 18313 - 18320. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hackzell, H. Uramoto, H. Izumi, K. Kohno, and K. Funa p73 Independent of c-Myc Represses Transcription of Platelet-derived Growth Factor beta -Receptor through Interaction with NF-Y J. Biol. Chem., October 11, 2002; 277(42): 39769 - 39776. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Zaika, N. Slade, S. H. Erster, C. Sansome, T. W. Joseph, M. Pearl, E. Chalas, and U. M. Moll {Delta}Np73, A Dominant-Negative Inhibitor of Wild-type p53 and TAp73, Is Up-regulated in Human Tumors J. Exp. Med., September 16, 2002; 196(6): 765 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Uramoto, H. Izumi, T. Ise, M. Tada, T. Uchiumi, M. Kuwano, K. Yasumoto, K. Funa, and K. Kohno p73 Interacts with c-Myc to Regulate Y-box-binding Protein-1 Expression J. Biol. Chem., August 23, 2002; 277(35): 31694 - 31702. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Stiewe, S. Zimmermann, A. Frilling, H. Esche, and B. M. Putzer Transactivation-deficient {Delta}TA-p73 Acts as an Oncogene Cancer Res., July 1, 2002; 62(13): 3598 - 3602. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Watanabe, T. Ozaki, T. Nakagawa, K. Miyazaki, M. Takahashi, M. Hosoda, S. Hayashi, S. Todo, and A. Nakagawara Physical Interaction of p73 with c-Myc and MM1, a c-Myc-binding Protein, and Modulation of the p73 Function J. Biol. Chem., April 19, 2002; 277(17): 15113 - 15123. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakagawa, M. Takahashi, T. Ozaki, K.-i. Watanabe, S. Todo, H. Mizuguchi, T. Hayakawa, and A. Nakagawara Autoinhibitory Regulation of p73 by {Delta}Np73 To Modulate Cell Survival and Death through a p73-Specific Target Element within the {Delta}Np73 Promoter Mol. Cell. Biol., April 15, 2002; 22(8): 2575 - 2585. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Balint, A. C. Phillips, S. Kozlov, C. L. Stewart, and K. H. Vousden Induction of p57KIP2 expression by p73beta PNAS, March 19, 2002; 99(6): 3529 - 3534. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Fontemaggi, A. Gurtner, S. Strano, Y. Higashi, A. Sacchi, G. Piaggio, and G. Blandino The Transcriptional Repressor ZEB Regulates p73 Expression at the Crossroad between Proliferation and Differentiation Mol. Cell. Biol., December 15, 2001; 21(24): 8461 - 8470. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Irwin and W. G. Kaelin p53 Family Update: p73 and p63 Develop Their Own Identities Cell Growth Differ., July 1, 2001; 12(7): 337 - 349. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |